GemOx-R regimen

WikiDoc Resources for GemOx-R regimen
Articles
Most recent articles on GemOx-R regimen Most cited articles on GemOx-R regimen Review articles on GemOx-R regimen Articles on GemOx-R regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on GemOx-R regimen Images of GemOx-R regimen Photos of GemOx-R regimen Podcasts & MP3s on GemOx-R regimen Videos on GemOx-R regimen
Evidence Based Medicine
Cochrane Collaboration on GemOx-R regimen Bandolier on GemOx-R regimen TRIP on GemOx-R regimen
Clinical Trials
Ongoing Trials on GemOx-R regimen at Clinical Trials.gov Trial results on GemOx-R regimen Clinical Trials on GemOx-R regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on GemOx-R regimen NICE Guidance on GemOx-R regimen NHS PRODIGY Guidance FDA on GemOx-R regimen CDC on GemOx-R regimen
Books
Books on GemOx-R regimen
News
GemOx-R regimen in the news Be alerted to news on GemOx-R regimen News trends on GemOx-R regimen
Commentary
Blogs on GemOx-R regimen
Definitions
Definitions of GemOx-R regimen
Patient Resources / Community
Patient resources on GemOx-R regimen Discussion groups on GemOx-R regimen Patient Handouts on GemOx-R regimen Directions to Hospitals Treating GemOx-R regimen Risk calculators and risk factors for GemOx-R regimen
Healthcare Provider Resources
Symptoms of GemOx-R regimen Causes & Risk Factors for GemOx-R regimen Diagnostic studies for GemOx-R regimen Treatment of GemOx-R regimen
Continuing Medical Education (CME)
CME Programs on GemOx-R regimen
International
GemOx-R regimen en Espanol GemOx-R regimen en Francais
Business
GemOx-R regimen in the Marketplace Patents on GemOx-R regimen
Experimental / Informatics
List of terms related to GemOx-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

GemOx-R regimen refers to a regimen consisting of rituximab, gemcitabine and oxaliplatin used to treat refractory and relapsing mantle cell lymphoma.

Regimen

GemGemcitabine

OxOxaliplatin

RRituximab

Indications

• Refractory and relapsing mantle cell lymphoma.